Carlos Rojas‐Fernandez

2.5k total citations · 1 hit paper
60 papers, 1.7k citations indexed

About

Carlos Rojas‐Fernandez is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Surgery. According to data from OpenAlex, Carlos Rojas‐Fernandez has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Geriatrics and Gerontology and 13 papers in Surgery. Recurrent topics in Carlos Rojas‐Fernandez's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Schizophrenia research and treatment (7 papers). Carlos Rojas‐Fernandez is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Schizophrenia research and treatment (7 papers). Carlos Rojas‐Fernandez collaborates with scholars based in Canada, United States and Australia. Carlos Rojas‐Fernandez's co-authors include Barbara Farrell, Wade Thompson, Kevin Pottie, Vivian Welch, Paul Moayyedi, Lise M. Bjerre, Lisa McCarthy, Welch, Kenneth Walsh and Vera Bittner and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and Journal of Alzheimer s Disease.

In The Last Decade

Carlos Rojas‐Fernandez

56 papers receiving 1.6k citations

Hit Papers

Deprescribing proton pump inhibitors: Evidence-based clin... 2017 2026 2020 2023 2017 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.
    2017 279 citations Barbara Farrell, Kevin Pottie et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Rojas‐Fernandez Canada 20 561 370 347 270 234 60 1.7k
Emmae Ramsay Australia 24 529 0.9× 116 0.3× 358 1.0× 183 0.7× 57 0.2× 55 1.6k
Sunny A. Linnebur United States 22 298 0.5× 154 0.4× 95 0.3× 157 0.6× 83 0.4× 75 1.4k
Susanna M. Wallerstedt Sweden 28 524 0.9× 771 2.1× 264 0.8× 162 0.6× 97 0.4× 128 3.1k
Luca Pasina Italy 28 1.4k 2.5× 195 0.5× 663 1.9× 421 1.6× 130 0.6× 122 2.8k
Shawn X. Sun United States 16 98 0.2× 314 0.8× 312 0.9× 276 1.0× 205 0.9× 57 1.7k
Mark J. Cziraky United States 25 317 0.6× 769 2.1× 533 1.5× 267 1.0× 38 0.2× 91 2.0k
Paul A. F. Jansen Netherlands 23 797 1.4× 159 0.4× 372 1.1× 454 1.7× 27 0.1× 57 1.7k
Rob J. van Marum Netherlands 29 824 1.5× 181 0.5× 449 1.3× 725 2.7× 29 0.1× 132 2.8k
Carlotta Franchi Italy 26 1.1k 2.0× 138 0.4× 596 1.7× 454 1.7× 53 0.2× 99 2.4k
Patrick D. Meek United States 13 646 1.2× 137 0.4× 252 0.7× 102 0.4× 108 0.5× 30 1.2k

Countries citing papers authored by Carlos Rojas‐Fernandez

Since Specialization
Citations

This map shows the geographic impact of Carlos Rojas‐Fernandez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Rojas‐Fernandez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Rojas‐Fernandez more than expected).

Fields of papers citing papers by Carlos Rojas‐Fernandez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Rojas‐Fernandez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Rojas‐Fernandez. The network helps show where Carlos Rojas‐Fernandez may publish in the future.

Co-authorship network of co-authors of Carlos Rojas‐Fernandez

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Rojas‐Fernandez. A scholar is included among the top collaborators of Carlos Rojas‐Fernandez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Rojas‐Fernandez. Carlos Rojas‐Fernandez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Poon, Stephanie, Carlos Rojas‐Fernandez, Sean Virani, George Honos, & Robert S. McKelvie. (2022). The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Inpatients With Heart Failure. CJC Open. 4(7). 636–643. 3 indexed citations
3.
Lintzeris, Nicholas, et al.. (2021). Strategies for Transfer From Methadone to Buprenorphine for Treatment of Opioid Use Disorders and Associated Outcomes: A Systematic Review. Journal of Addiction Medicine. 16(2). 143–151. 12 indexed citations
4.
Bjerre, Lise M., Barbara Farrell, Matthew Hogel, et al.. (2018). Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.. PubMed. 64(1). 17–27. 137 indexed citations
5.
Moriarty, Frank, Kevin Pottie, Lisa Dolovich, et al.. (2018). Deprescribing recommendations: An essential consideration for clinical guideline developers. Research in Social and Administrative Pharmacy. 15(6). 806–810. 22 indexed citations
6.
Farrell, Barbara, Kevin Pottie, Carlos Rojas‐Fernandez, et al.. (2017). Déprescrire les inhibiteurs de la pompe à protons: Lignes directrices de pratique clinique fondées sur les données probantes.. Canadian Family Physician. 63(5). 1 indexed citations
7.
8.
Farrell, Barbara, Kevin Pottie, Carlos Rojas‐Fernandez, et al.. (2016). Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing. PLoS ONE. 11(8). e0161248–e0161248. 94 indexed citations
9.
Black, Cody, Wade Thompson, Vivian Welch, et al.. (2016). Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review. Diabetes Therapy. 8(1). 23–31. 33 indexed citations
10.
11.
Rojas‐Fernandez, Carlos, et al.. (2015). Statins and Cognitive Side Effects. Cardiology Clinics. 33(2). 245–256. 11 indexed citations
12.
Rojas‐Fernandez, Carlos, et al.. (2015). Use of fall risk increasing drugs in residents of retirement villages: a pilot study of long term care and retirement home residents in Ontario, Canada. BMC Research Notes. 8(1). 568–568. 9 indexed citations
13.
Rojas‐Fernandez, Carlos, et al.. (2014). Psychotropic and Cognitive-Enhancing Medication Use and Its Documentation in Contemporary Long-term Care Practice. Annals of Pharmacotherapy. 48(4). 438–446. 11 indexed citations
14.
Rojas‐Fernandez, Carlos, Larry B. Goldstein, Allan I. Levey, Beth A. Taylor, & Vera Bittner. (2014). An assessment by the Statin Cognitive Safety Task Force: 2014 update. Journal of clinical lipidology. 8(3). S5–S16. 83 indexed citations
15.
Rojas‐Fernandez, Carlos, Anne L. Stephenson, Hadas D. Fischer, et al.. (2014). Current Use of Domperidone and Co-prescribing of Medications that Increase Its Arrhythmogenic Potential Among Older Adults: A Population-Based Cohort Study in Ontario, Canada. Drugs & Aging. 31(11). 805–813. 4 indexed citations
16.
Xu, Ke & Carlos Rojas‐Fernandez. (2003). Ancillary Community Pharmacy Services Provided to Older People in A Largely Rural and Ethnically Diverse Region: A Survey of Consumers in West Texas. The Journal of Rural Health. 19(1). 79–86. 20 indexed citations
17.
Rojas‐Fernandez, Carlos, Kate L. Lapane, Chris MacKnight, & Kellee Howard. (2002). Undertreatment of Osteoporosis in Residents of Nursing Homes: Population-Based Study with Use of the Systematic Assessment of Geriatric Drug Use Via Epidemiology (Sage) Database. Endocrine Practice. 8(5). 335–342. 23 indexed citations
18.
Rojas‐Fernandez, Carlos. (2001). Successful Use of Donepezil for the Treatment of Dementia with Lewy Bodies. Annals of Pharmacotherapy. 35(2). 202–205. 38 indexed citations
19.
Rojas‐Fernandez, Carlos, Krista L. Lanctôt, David D. Allen, & Chris MacKnight. (2001). Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: Time for a Different Paradigm?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(1). 74–102. 19 indexed citations
20.
Bond, Christopher, et al.. (2000). Psychotropic Drugs and Falls: New Evidence Pertaining to Serotonin Reuptake Inhibitors. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(3). 308–317. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmae Ramsay Breakdown of academic impact, for papers by Sunny A. Linnebur Breakdown of academic impact, for papers by Susanna M. Wallerstedt Breakdown of academic impact, for papers by Luca Pasina Breakdown of academic impact, for papers by Shawn X. Sun Breakdown of academic impact, for papers by Mark J. Cziraky Breakdown of academic impact, for papers by Paul A. F. Jansen Breakdown of academic impact, for papers by Rob J. van Marum Breakdown of academic impact, for papers by Carlotta Franchi Breakdown of academic impact, for papers by Patrick D. Meek
Rankless by CCL
2026